Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FYN | P06241 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20093503 | 0.85 | FYN (0.32) | FYN | |
| SCHEMBL23356488 | 0.85 | FYN (0.32) | FYN | |
| SCHEMBL18517334 | 0.83 | — | — | |
| SCHEMBL26544412 | 0.83 | — | — | |
| SCHEMBL13635239 | 0.82 | DRD2 (0.34) | FYN | |
| SCHEMBL13407516 | 0.81 | TLR4 (0.30) | — | |
| SCHEMBL13389628 | 0.81 | TLR4 (0.30) | — | |
| SCHEMBL4404563 | 0.81 | DRD2 (0.35) | FYN | |
| SCHEMBL16995031 | 0.81 | DRD2 (0.35) | FYN | |
| SCHEMBL13407519 | 0.81 | DRD2 (0.35) | FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1409441-B1 | INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY | MERCK PATENT GMBH (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-1409441-B1 | INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY | MERCK PATENT GMBH (DE) | 2009-11-18 | — | — | EP | disclosed |
| US-7122228-B2 | Transistros; liquid crystals display; electrooptics | MERCK PATENT GMBH (DE) | 2006-10-17 | — | — | US | disclosed |
| US-20040171866-A1 | Transistros; liquid crystals display; electrooptics | MERCK PATENTGESELLSCHAFT (DE) | 2004-09-02 | — | — | US | disclosed |
| EP-1409441-A1 | INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY | MERCK PATENT GmbH (DE) | 2004-04-21 | — | — | EP | disclosed |
| WO-2003010120-A1 | INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY | MERCK PATENT GMBH (DE) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171866-A1 | Transistros; liquid crystals display; electrooptics | VCL, RIF1, IPO11 | FYN 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.